Express News | Adial Pharmaceuticals FY 2024 GAAP EPS $(2.72) Beats $(2.97) Estimate

BenzingaMar 4 09:50 ET

10-K: Annual report

SECMar 4 08:50 ET · Announcements

Adial Pharmaceuticals Expects Cash to Fund Operations Into 2H of 2025

TipRanksMar 4 08:36 ET

Adial Pharma Believes Existing Cash and Cash Equivalents Will Fund Oper Expenses Into 2H

Dow JonesMar 4 08:31 ET

Express News | Adial Pharmaceuticals FY Net Income USD -13.2 Million

ReutersMar 4 08:30 ET

Adial Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Feedback for Its Vitro Bridging Strategy of AD04 and Will Proceed to Manufacture Clinical Supplies for Its Upcoming Phase 3 Clinical Trial.

BenzingaFeb 25 09:05 ET